{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:56:21Z","timestamp":1753890981616,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative therapy for hematologic malignancies. Alloreactivity after HSCT is known to be mediated by adaptive immune cells expressing rearranging receptors. Recent studies demonstrated that the innate immune system could likewise sense the non-self signals and subsequently enhance the alloimmune response. We recently demonstrated that the donor\/recipient mismatch of signal regulatory protein \u03b1 (SIRP\u03b1), an immunoglobulin receptor exclusively expressed on innate cells, is associated with a higher risk of cGVHD and relapse protection in a cohort of acute myeloid leukemia patients who underwent allo-HSCT. Whether these effects also occur in other hematologic malignancies remains unclear. In the present study, we compared outcomes by SIRP\u03b1 match status in a cohort of 310 patients who received allo-HSCT from an HLA matched-related donor for the treatment of lymphoid malignancies. Multivariable analysis showed that SIRP\u03b1 mismatch was associated with a significantly higher rate of cGVHD (hazard ratio [HR] 1.8, P= .002), cGVHD requiring systemic immunosuppressive therapy (HR 1.9, P= .005), a lower rate of disease progression (HR 0.5, P= .003) and improved progression-free survival (HR 0.5, P= .001). Notably, the effects of SIRP\u03b1 mismatch were observed only in the patients who achieved &amp;gt;95% of donor T-cell chimerism. The mismatch in SIRP\u03b1 is associated with favorable relapse protection and concurrently increased risk of cGVHD in patients who undergo allo-HSCT for lymphoid malignancies, and the optimal donor could be selected based on the finding of the study to mitigate the risk of GVHD and relapse.<\/jats:p>","DOI":"10.3389\/fimmu.2022.904718","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T08:43:44Z","timestamp":1657183424000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["SIRP\u03b1 Mismatch Is Associated With Relapse Protection and Chronic Graft-Versus-Host Disease After Related Hematopoietic Stem Cell Transplantation for Lymphoid Malignancies"],"prefix":"10.3389","volume":"13","author":[{"given":"Rima M.","family":"Saliba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer A.","family":"Srour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uri","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudith","family":"Carmazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Moller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan O.","family":"Ciurea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyanuch","family":"Kongtim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Rondon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supawee","family":"Saengboon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin M.","family":"Alousi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katayoun","family":"Rezvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Shpall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard E.","family":"Champlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk Factors for Acute GVHD and Survival After Hematopoietic Cell Transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15497","article-title":"SIRPalpha\/CD47 Axis Controls the Maintenance of Transplant Tolerance Sustained by Myeloid-Derived Suppressor Cells","volume":"19","author":"Pengam","year":"2019","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surgeons"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aam6202","article-title":"Donor SIRPalpha Polymorphism Modulates the Innate Immune Response to Allogeneic Grafts","volume":"2","author":"Dai","year":"2017","journal-title":"Sci Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI133909","article-title":"Donor Monocyte-Derived Macrophages Promote Human Acute Graft-Versus-Host Disease","volume":"130","author":"Jardine","year":"2020","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004307","article-title":"Mismatch in SIRPalpha, a Regulatory Protein in Innate Immunity, is Associated With Chronic GVHD in Hematopoietic Stem Cell Transplantation","volume":"5","author":"Saliba","year":"2021","journal-title":"Blood Adv"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/ni1527","article-title":"Polymorphism in Sirpa Modulates Engraftment of Human Hematopoietic Stem Cells","volume":"8","author":"Takenaka","year":"2007","journal-title":"Nat Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.550558","article-title":"Polymorphisms in the Human Inhibitory Signal-Regulatory Protein Alpha do Not Affect Binding to its Ligand CD47","volume":"289","author":"Hatherley","year":"2014","journal-title":"J Biol Chem"},{"key":"B8","unstructured":"Pre-HCT Preparative Regimen (Conditioning), Form 24002020"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.07.005","article-title":"Mixed T Lymphocyte Chimerism After Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood marrow Transplant J Am Soc Blood Marrow Transplantation"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601054","article-title":"Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-Versus-Host Disease","volume":"197","author":"Hakim","year":"2016","journal-title":"J Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i10.1793","article-title":"Macrophage Regulation of Graft-vs-Host Disease","volume":"8","author":"Hong","year":"2020","journal-title":"World J Clin Cases"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2017.04.019","article-title":"Association of Plasma CD163 Concentration With De Novo-Onset Chronic Graft-Versus-Host Disease","volume":"23","author":"Inamoto","year":"2017","journal-title":"Biol Blood marrow Transplant J Am Soc Blood Marrow Transplantation"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-008-0132-5","article-title":"Reconstitution of the Immune System After Hematopoietic Stem Cell Transplantation in Humans","volume":"30","author":"Storek","year":"2008","journal-title":"Semin Immunopathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.145","article-title":"Sensitivity of Hematological Malignancies to Graft-Versus-Host Effects: An EBMT Megafile Analysis","volume":"28","author":"Stern","year":"2014","journal-title":"Leukemia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018027003","article-title":"The Impact of the Graft-Versus-Leukemia Effect on Survival in Acute Lymphoblastic Leukemia","volume":"3","author":"Yeshurun","year":"2019","journal-title":"Blood Adv"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI74370","article-title":"Non-Self Recognition by Monocytes Initiates Allograft Rejection","volume":"124","author":"Oberbarnscheidt","year":"2014","journal-title":"J Clin Invest"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902194","article-title":"An Innate Response to Allogeneic Nonself Mediated by Monocytes","volume":"183","author":"Zecher","year":"2009","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2006-12-022038","article-title":"The Role of Antigen-Presenting Cells in Triggering Graft-Versus-Host Disease and Graft-Versus-Leukemia","volume":"110","author":"Chakraverty","year":"2007","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.278993","article-title":"Refined HLA-DPB1 Mismatch With Molecular Algorithms Predicts Outcomes in Hematopoietic Stem Cell Transplantation","volume":"107","author":"Zou","year":"2021","journal-title":"Haematologica"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.011","article-title":"The CD47-SIRPalpha Immune Checkpoint","volume":"52","author":"Logtenberg","year":"2020","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200839","article-title":"The SIRPalpha-CD47 Immune Checkpoint in NK Cells","volume":"218","author":"Deuse","year":"2021","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s41467-019-08637-9","article-title":"A Functional Subset of CD8(+) T Cells During Chronic Exhaustion is Defined by SIRPalpha Expression","volume":"10","author":"Myers","year":"2019","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.001136\/jitc-002019-000413","article-title":"The Fully Human Anti-CD47 Antibody SRF231 Exerts Dual-Mechanism Antitumor Activity via Engagement of the Activating Receptor CD32a","volume":"8","author":"Peluso","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1710877114","article-title":"Anti-SIRPalpha Antibody Immunotherapy Enhances Neutrophil and Macrophage Antitumor Activity","volume":"114","author":"Ring","year":"2017","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02018","article-title":"First-In-Human, First-In-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers","volume":"37","author":"Sikic","year":"2019","journal-title":"J Clin Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2332","article-title":"Engineering Macrophages to Phagocytose Cancer Cells by Blocking the CD47\/SIRPa Axis","volume":"8","author":"Yang","year":"2019","journal-title":"Cancer Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nature23270","article-title":"In Vivo CRISPR Screening Identifies Ptpn2 as a Cancer Immunotherapy Target","volume":"547","author":"Manguso","year":"2017","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-347286","article-title":"Effect of MHC and non-MHC Donor\/Recipient Genetic Disparity on the Outcome of Allogeneic HCT","volume":"120","author":"Warren","year":"2012","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-07-728063","article-title":"Replication of Associations Between Genetic Polymorphisms and Chronic Graft-Versus-Host Disease","volume":"128","author":"Martin","year":"2016","journal-title":"Blood"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.904718\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T08:43:47Z","timestamp":1657183427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.904718\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2022.904718"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.904718","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"article-number":"904718"}}